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Matrix metalloproteinase-1 (MMP-1) is increased in inﬂammatory conditions leading to destruction
of extracellular matrix. Many inﬂammatory stimuli activate sphingomyelinases (SMases), which
generate ceramide. We aimed to deﬁne the relevance and type of SMase responsible for the regula-
tion of MMP-1. Acid sphingomyelinase (ASM)-deﬁcient human ﬁbroblasts failed to phosphorylate
extracellular signal-regulated kinase (ERK), or upregulate MMP-1 mRNA and protein expression
upon stimulation with interleukin-1 beta (IL-1b), whereas phosphorylation of p38 mitogen-acti-
vated protein kinase and IL-8 production remained unaffected. Transfection of ASM restored
MMP-1 production. Addition of exogenous SMase was sufﬁcient to restore activation of ERK and
increase MMP-1 mRNA. Inhibition of ASM with imipramine completely abrogated MMP-1 induction.
The results suggest that IL-1b-induced expression of MMP-1 is dependent on ASM.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction human diseases [8–10]. MMP-1 is increased upon stimulation withRemodeling of extracellular matrix (ECM) is a necessary process
for inﬂammatory disorders, physiologic development, growth, and
tissue repair. Matrix metalloproteinases (MMPs) are a family of
zinc-dependent metalloendopeptidases collectively capable of
degrading essentially all ECM components [1,2]. Most of the MMPs
are secreted as proenzymes and require proteolytic cleavage for
activation [3,4]. Activity of MMPs is further regulated by a group
of endogenous proteins, so called tissue inhibitors of metallopro-
teinases (TIMPs) that bind to active and alternative sites of acti-
vated MMPs [5]. The balance of activated MMPs and TIMPs is
crucial to maintain tissue allostasis. Excessive production or acti-
vation of MMPs results in uncontrolled degradation of ECM [3,6,7].
Matrix metalloproteinase-1 (MMP-1), also called interstitial
collagenase, is of pathophysiological relevance for tumor invasion
and metastasis, pulmonary emphysema, rheumatoid arthritis, ﬁ-
brotic disorders, intestinal and dermal ulcerations and many otherchemical Societies. Published by E
, extracellular matrix; ERK,
ukin-1 beta; MMP, matrix
p38MAPK, p38 mitogen-acti-
otein kinase/Jun N-terminal
e kinase; S1P, sphingosine-1
TNF, tumor necrosis factor
.
rg.de (J. Bock).inﬂammatory cytokines such as interleukin-1 beta (IL-1b), tumor
necrosis factor (TNF) [11], ionizing radiation [12] or UVA irradia-
tion [13]. Expression of MMP-1 has been linked with ceramide
metabolism via activation of extracellular signal-regulated and
stress-activated protein kinase pathways [14,15] but the relevance
of this association for the mentioned stimuli remains to be deter-
mined. Reunanen et al. investigated the effects of exogenous neu-
tral sphingomyelinase (NSM) and cell-permeable C2-ceramides
[14]. This resulted in stimulation of MMP-1 expression, activation
of extracellular signal-regulated kinase (ERK), stress-activated
protein kinase/Jun N-terminal kinase (SAPK/JNK) and p38 mito-
gen-activated protein kinase (p38MAPK) but the involvement
and relevance of endogenous sphingomyelinases (SMases) respon-
sible for ceramide generation was not investigated. Bu et al.
showed that sphingosine kinase (SphK), which catalyzes formation
of sphingosine-1 phosphate (S1P) and dihydrosphingosine 1-phos-
phate (dhS1P) is a key regulator of MMP-1 production [15]. SphK
phosphorylates sphingosine generated by ceramidase and there-
fore represents a lipid kinase utilizing the lipid mediator arising
from signaling events leading to formation of ceramide.
The sphingolipid ceramide, generated by signal-activated
SMases, has emerged as a second messenger of stimuli as diverse
as ligation of various receptors, ionizing radiation, chemotherapy
or infectionwith some bacteria and viruses [16]. SMases are charac-
terized by their optimal pH and are divided accordingly into acid,lsevier B.V. All rights reserved.
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SMases, named acidic, secretory, Mg2+-dependent neutral, Mg2+-
independent neutral, alkaline and bacterial enzymes with both
phospholipaseCandSMase activity [17]. Theacid sphingomyelinase
(ASM) contributes to lysosomal sphingomyelin turnover and is also
secreted upon cellular treatmentwith inﬂammatory stimuli [16]. In
contrast, neutral SMase is membrane-bound, alkaline SMase is
found in the bile [18]. Activation of SMases is followed by rapid
hydrolysis of plasma membrane sphingomyelin to the second mes-
senger ceramide [16]. Ceramide has been shown to be involved in a
variety of cellular responses like apoptosis or cell senescence [19]. It
has also been reported to induce MAPK pathways [14,15] and regu-
late the transcription of cyclooxygenase-2 [20].
ASM-activating cytokines and stimuli greatly overlap with the
stimulatory processes which increase MMP-1 expression, as IL-1b,
TNF [21–23], ionizing radiation [24] and UVA irradiation [25]. Con-
sidering the similarities between ASM-activation and upregulation
ofMMP-1expression, aswell as the linkageofMMP-1with ceramide
metabolism, we hypothesized that ASMmay be relevant for MMP-1
expression upon stimulation. To test this hypothesis we employed a
genetic model with human dermal ﬁbroblasts from a patient with
genetic deﬁciency for ASM (Niemann-Pick disease, [26]).
In this study, we show that ASM is necessary for upregulation of
MMP-1 expression upon stimulationwith IL-1b. Thus, ceramide not
only induces MMP-1 expression but is required to activate ERK and
upregulate MMP-1 expression upon stimulation with IL-1b.
2. Materials and methods
2.1. Cells and reagents
The human ASM+/+ and ASM/ skin ﬁbroblasts were a kind gift
from Dr. Gulbins, Essen, Germany. Cells were maintained in Dul-
becco’s minimum essential medium (DMEM), supplemented with
10% fetal calf serum (FCS), 1% penicilline/streptavidine, 1% non-
essential amino acids and 1% sodium pyruvate in an atmosphere
containing 10% CO2 at 37 C. FCS was inactivated for 1 h, 50 C.
For quantiﬁcation of MMP-1 by ELISA, experiments were per-
formed without FCS. SMase from staphylococcus aureus, methyl-
b-cyclodextrin, imipramine and L-carnitine were purchased from
Sigma–Aldrich, Germany. IL-1b and MMP-1 ELISA were purchased
from R&D Systems, Germany.
2.2. Antibodies
The following antibodies were used for Western blot analysis:
Rabbit monoclonal anti-phospho ERK p44/42 (ERK 1/2) and rabbit
polyclonal anti-phospho p38MAPK from cell signaling Danvers,
MA, USA. Secondary goat anti-rabbit and goat anti-mouse antibod-
ies were from Santa Cruz Biotechnology, Santa Cruz, CA, USA. The
mouse polyclonal anti c-myc antibodies (clone 9E10) (hybridoma
cell line) were a kind gift from Dr. Werner Falk, University Hospital,
Regensburg, Germany.2.3. RNA extraction and reverse transcriptase (RT)-polymerase chain
reaction (PCR)
Fibroblasts were stimulated with IL-1b (1 ng/ml) or exogenous
SMase (0.1 U/ml) for 6 h. After stimulation, RNA was isolated using
Qiagen RNA isolation kit (Qiagen, Hilden, Germany) and RT-PCR
was arranged. All samples were reverse-transcribed using reverse
transcriptase kit (Promega, Madison, WI, USA). RT-PCR assay was
performed to speciﬁcally quantify mRNA level. The cDNA template
(50 ng/well) was isolated from ﬁbroblasts, 750 nM of each forward
and reverse primer and 250 nM ﬂuorigenic probe were inserted.Amplicons were deﬁned by gene speciﬁc oligonucleotide primers.
Within these amplicons, an oligonucleotide probe labeled with a
reporter dye 6-FAM for MMP-1 isoform and VIC for GAPDH cova-
lently linked at the 50 end and a quencher dye TAMRA (6-car-
boxy-tetramethyl-rhodamine) was linked to the 30 end of the
probe. Reactions were performed in triplicate in a 384-well plate
(Abgene, Epsom, UK). In all assays, cDNA was ampliﬁed using a
standardized program (10 min denaturing step; 35 cycles of
1 min at 94 C, 1 min at 55 C and 1 min at 72 C) (Applied Biosys-
tem, CA, USA). To test integrity of the cDNA, RT-PCR with GAPDH
was performed. The primers used for MMP-1 were synthesized
by MWG Biotech (Ebersberg, Germany).
 Forward primer: TTT CAT TTC TGT TTT CTG GCC A
 Reverse primer: CAT CTC TGT CGG CAA ATT CGT
 Probe: AAC TGC CAA ATC GGC TTG AAG CTG CT
The amount of reporter dye ﬂuorescence was monitored using
Sequence Detector Software (SDS version 2.2, PE Applied Biosys-
tems). Reporter dye ﬂuorescence versus PCR cycles was plotted.
Fluorescence values of GAPDH were subtracted from those of
MMP-1 isoform. The values of cDNA were subtracted from those
of control cDNA and the relative start amount of cDNA was calcu-
lated in consideration of the exponential ampliﬁcation.
2.4. Transfection/cell sorting
ASM-deﬁcient ﬁbroblasts were transfected with the plasmid
pJK+ASM, to reconstitute expression of ASM, or empty control vec-
tor (pJK). For transfection, FuGene transfection solution (Roche,
Mannheim, Germany) was applied, according to the manufac-
turer’s recommendations. Because of low rates of transfection,
ﬁbroblasts were sorted for transfected cells 24 h after transfection.
The pJK vector contains an elongation factor promoter to induce
constitutive protein expression and simultaneous surface expres-
sion of a myc-tag that allows selection of transfected cells [27].
Therefore, cells were immunoprecipitated with mouse anti-c myc
(9E10) (1:500) antibodies for 4 h. Labeled cells were immobilized
on protein A/G agarose beads (Santa Cruz Biotechnology) by incu-
bation for additional 60 min. Immunocomplexes were washed four
times with 500 ll ice cold PBS and centrifuged at 800 rpm for
1 min, 4 C. Immunoprecipitated cells were seeded in 12-well
plates and used for experiments 24 h later.
2.5. MMP-1 and IL-8 ELISA
For detection of MMP-1 and IL-8, ﬁbroblasts were seeded in 12-
well plates. Transfected cells were prepared as described above.
Experiments were performed in medium without FCS and cells
were incubated with the indicated substances. For pharmacologic
inhibition of ASM, imipramine (30 lM) was used. For inhibition
of NSM, cells were incubated with L-carnitine (10 lg/ml). Concen-
tration of MMP-1 in supernatants was determined by ELISA (R&D
Systems; Minneapolis, MA, USA), as recommended by the manu-
facturer. All measurements were performed in duplicate. IL-8
was measured by ELISA as described elsewhere [28].
2.6. Phosphorylation of p38MAPK and ERK1/2
To determine phosphorylation of p38MAPK and ERK1/2, cells
were seeded in six-well plates. Subconﬂuent layers of cells were
stimulated with IL-1b (1 ng/ml) for the indicated times. The reac-
tion was terminated by addition of 200 ll ice-cold lysis buffer con-
sisting of 25 mM HEPES, pH 7.4, 0.1% SDS, 0.5% deoxycholate, 1%
Triton X-100, 125 mM NaCl, 10 mM NaF, 10 mM Na3VO4, 10 mM
sodium pyrophosphate and 10 lg/ml each of aprotinin and leupep-
tin. Insoluble debris was removed by centrifugation at 8000 rpm
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mined using bicinchoninic acid solution (BCA) and copper(II) sul-
fate solution (1:50) (Sigma–Aldrich, Germany). Supernatants
were added to 1  SDS sample buffer and 5% 2-mercaptoethanol.
Equal amounts of protein were separated by SDS–PAGE (4–12%
Tris–glycine gel, Invitrogen, Carlsbad, CA, USA) and electrophoret-
ically transferred to nitrocellulose membranes. Membranes were
blocked with 4% bovine serum albumin (BSA) in TBST (0.5 M
Tris–HCl pH 6.8, 150 mM NaCl and 0.1% Tween 20) and incubated
overnight at 4 C with the indicated primary antibodies. The anti-
phospho p38MAPK antibodies were diluted 1:1000, the anti-phos-
pho-p44/42 antibodies 1:1000 and the anti-b-actin antibodies
1:3000. The membranes were further incubated with horse-radish
peroxidase-conjugated secondary antibodies, and protein bands
were visualized using a commercial chemiluminescence detection
kit (ECL plus, Amersham Biosciences).
2.7. ASM-activity assay
ASM+/+ and ASM/-ﬁbroblasts were seeded in six-well plates
and analyzed for activity of ASM as described by Takahashi et al.
[29] with some modiﬁcations. In brief, cells were washed with
ice-cold PBS, containing Ca2+, and lysed with 120 ll of lysis buffer
(PBS with Ca2+ and 4% Triton). Cellular debris was removed by cen-
trifugation at 10000 rpm for 10 min, 4 C. One hundred microliters
of supernatants were added to equal amounts of reaction buffer
(1 M Na-acetate, pH 5.0, 10 mM ZnCl2 and H2O), containing 14C-la-
beled sphingomyelin (bovine) (NEC-663 [choline-methyl-14C], Per-
kin–Elmer Life and Analytical Science, Boston, MA, USA). Samples
were rocked for 60 min at 37 C. Reactions were stopped by addi-
tion of 200 ll 20% trichloroacetic acid and 100 ll 5% BSA. Scintilla-
tion was detected with a liquid scintillation analyzer 1600TR Tri-
Carb (Canberra Packard, Dreieich, Germany).
2.8. Statistical analysis
Data are shown using vertical Box-Whisker plots (25% and 75%
values), generated in the basic module of the program SigmaStat.
Statistical analysis was performed by Mann–Whitney U-test, with
P < 0.05 considered statistically signiﬁcant. Data are given as
means ± S.E.M.
3. Results
3.1. ASM-deﬁcient ﬁbroblasts fail to upregulate MMP-1-mRNA and -
protein production upon stimulation with IL-1b
To elucidate the role of ASM for MMP-1 expression we ﬁrst
analyzed MMP-1-mRNA expression by RT-PCR. Fibroblasts withFig. 1. ASM+/+, but not ASM/, ﬁbroblasts increase MMP-1-mRNA and -protein product
exogenous SMase (0.1 U/ml). RNA was isolated after 6 h and MMP-1 mRNA levels were a
ELISA, 24 h after engagement with IL-1b (0, 1 or 1 ng/ml, n = 6; P < 0.05).ASM-deﬁciency (ASM/) and control-ﬁbroblasts (ASM+/+) were
stimulated with IL-1b or exogenous SMase for 6 h before RNA
was isolated. Control ﬁbroblasts showed an 8.4-fold increase
(±2.6) of MMP-1-mRNA upon stimulation with IL-1b whereas
ASM/-ﬁbroblasts failed to upregulate MMP-1-mRNA (1.5-fold
±0.25, P < 0.05, Fig. 1A). Addition of exogenous SMase was sufﬁ-
cient to increase MMP-1-mRNA-expression in ASM-deﬁcient
ﬁbroblasts by 17.5-fold (±7.7) and conﬁrmed principal ability of
ASM/-ﬁbroblasts to upregulate MMP-1 (Fig. 1A). ASM+/+ ﬁbro-
blasts did not activate MMP-1-mRNA production upon addition of
exogenous SMase (1.74-fold ±0.36, Fig. 1A), excluding contaminants
of exogenous SMasewhichmight provide a second signal forMMP-1
production. Thus, ASM-sufﬁcient ﬁbroblasts need IL-1b to upregu-
late MMP-1 production while in ASM-deﬁcient ﬁbroblasts enzy-
matic activity of exogenous SMase is sufﬁcient to induce MMP-1,
most likely due to accumulated sphingomyelin in ASM/ cells
which is rapidlyhydrolysed to ceramidebyexogenous SMase, there-
by eliciting cell signaling which is blocked in ASM-deﬁcient cells.
Protein analysis of MMP-1, 24 h after exposure to IL-1b also re-
vealed a 2.7-fold (±0.38) increase of MMP-1 concentration in
supernatants of ASM+/+-ﬁbroblasts, while the concentration of
MMP-1 in supernatants of ASM/-ﬁbroblasts was 1.55 ± 0.11
(P < 0.05, Fig. 1B). ASM-activity of cells was determined to ensure
genetic deﬁciency. ASM/-cells showed less than 5% of ASM-activ-
ity when compared to ASM+/+-cells (data not shown).3.2. Transfection of ASM restores MMP-1 production upon stimulation
with IL-1b, whereas upregulation of IL-8 is not inﬂuenced
ASM/ ﬁbroblasts were transfected with an expression plas-
mid for ASM (pJK-ASM) to proof ASM-dependence of MMP-1 regu-
lation. The next day, 1 day prior to stimulation with IL-1b,
ﬁbroblasts were sorted for transfected cells utilizing the myc-tag
simultaneously expressed by cells transfected with the vector pJK.
Concentration of MMP-1 in supernatants was analyzed by ELISA
24 h after stimulation with IL-1b. Transfection of ASM/ ﬁbro-
blasts with pJK-ASM increased MMP-1 expression upon stimula-
tion with IL-1b by 2.4-fold ±0.3 (P = 0.013) ( Fig. 2A), and thus,
restored MMP-1 production. ASM/ ﬁbroblasts transfected with
the control plasmid pJK or unstimulated ﬁbroblasts transfected
with pJK-ASM showed no increase of MMP-1 expression (1.2-fold
±0.2, 1.1-fold ±0.11, respectively, Fig. 2A). These data identify
ASM as an important enzyme for MMP-1 expression after engage-
ment with IL-1b. Unfortunately, the ﬁbroblasts used did not upreg-
ulate MMP-1 production after addition of TNF, and thus, this
pathway could not be investigated in our cell model.
IL-8 was determined to compare MMP-1 secretion with another
signaling pathway activated by IL-1b, and to demonstrateion upon stimulation with IL-1b. (A) Cells were stimulated with IL-1b (1 ng/ml) or
nalyzed by RT-PCR (n = 4; P < 0.05). (B) Quantiﬁcation of MMP-1 in supernatants by
Fig. 2. Transfection of ASM restores MMP-1 production. (A) ASM-deﬁcient ﬁbroblasts were transfected with an ASM expression plasmid (pJK-ASM) or an empty control
vector (pJK). MMP-1 production in supernatants was analyzed by ELISA, 24 h after engagement with IL-1b (1 ng/ml, P = 0.013, n = 5). (B) For comparison IL-8 was determined
in the same supernatants of transfected cells.
918 J. Bauer et al. / FEBS Letters 583 (2009) 915–920sensitivity of ASM/ ﬁbroblasts for engagement with IL-1b. Con-
centration of IL-8 was determined by ELISA and measured in the
same supernatants of transfected cells which were used for
MMP-1 analysis. The increase of IL-8 following engagement with
IL-1b was comparable in all cells, independent of transfection with
ASM ( Fig. 2B). Cells transfected with the empty vector (pJK)
showed a 2.0-fold ±0.2 increase of IL-8, cells transfected with
pJK-ASM 2.15-fold ±0.1. These results revealed that ASM/ ﬁbro-
blasts are sensitive for stimulation with IL-1b and do not differ in
the upregulation of IL-8.3.3. ASM is required for activation of ERK but not p38MAPK after
engagement with IL-1b
Activation of different MAPK represents early signaling events
after engagement with IL-1b. To further localize the signaling de-
fect, we tested whether ASM-deﬁcient cells show a failure in the
initiation of intracellular signals elicited by IL-1b. To this end, we
determined the phosphorylation of ERK and p38MAPK in ASM/
and ASM+/+ ﬁbroblasts by Western-blotting. The results revealed
that ASM-deﬁcient cells failed to phosphorylate ERK upon treat-
ment with IL-1b while activation of p38MAPK was comparable to
control ﬁbroblasts (Fig. 3A and B). To exclude inadequate stimula-
tion, causing deﬁcient phosphorylation of ERK, the cell lysates with
clear p38MAPK activation were analyzed for ERK phosphorylation.
To simulate the conditions such as ASM+/+ ﬁbroblasts, we added
exogenous SMase (0.1 U/ml) to ASM/ ﬁbroblasts. This was sufﬁ-
cient to restore ERK-phosphorylation in ASM/ ﬁbroblasts upon
stimulation with IL-1b (Fig. 3C).Fig. 3. Activation of ERK1/2 depends on ASM. Fibroblasts were stimulated for the
indicated times with IL-1b (1 ng/ml) or exogenous SMase (0.1 U/ml). Phosphory-
lation of ERK1/2 and p38MAPK was determined by Western-blotting using
phospho-speciﬁc antibodies. (A) Stimulation of ASM+/+ ﬁbroblasts results in
phosphorylation of ERK1/2 and p38MAPK (n = 5). (B) ASM/ ﬁbroblasts fail to
phosphorylate ERK1/2, while p38MAPK is rapidly phosphorylated (n = 5). (C)
Exogenous SMase restores phosphorylation of ERK1/2 in ASM/ ﬁbroblasts.3.4. MMP-1 induction is abrogated by inhibition of ASM and
destruction of lipid rafts, while inhibition of NSM is not effective
In order to determine the possibility of MMP-1 regulation by
inhibition of ASM, ASM+/+ ﬁbroblasts were incubated with imipra-
mine to inhibit ASM prior to stimulation. Expression of MMP-1 in
supernatants was measured by ELISA, 24 h after stimulation with
IL-1b. Cells stimulated with IL-1b showed an increase of MMP-1
by 8.4-fold ±2.8 while cells treated with the ASM-inhibitor imipra-
mine (30 lM) only displayed an increase of MMP-1 by 0.6 ± 0.16-
fold (P = 0.016) upon stimulation with IL-1b (Fig. 4A). Inhibition
of NSM by L-carnitine had no effect on the concentration of
MMP-1 following engagement with IL-1b (Fig. 4B). This indicatesthat inhibition of ASM is sufﬁcient to effectively reduce expression
of MMP-1. Destruction of lipid rafts by extraction of cholesterol
with methyl-b-cyclodextrin (10 mM) also inhibited the activation
of MMP-1 (0.5-fold ±0.17) (Fig. 4C).
Fig. 4. Inhibition of ASM by imipramine abrogates MMP-1 upregulation by IL-1b.
Concentrations of MMP-1 in supernatants were determined by ELISA, 24 h after
stimulation with IL-1b (1 ng/ml). (A) ASM+/+ ﬁbroblasts were incubated with
imipramine, 30 lm, prior to stimulation with IL-1b (P < 0.01, n = 6). (B) Inhibition
of NSM with L-carnitine (10 lg/ml) prior to stimulation with IL-1b (n = 4). (C)
ASM+/+ ﬁbroblasts were incubated with methyl-b-cyclodextrin (10 lM) (P < 0.01).
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In this study, we show that ASM is required for induction of
MMP-1 upon stimulation with IL-1b in human ﬁbroblasts. We uti-
lized RT-PCR and protein analysis to detect the dependence on
ASM for the expression of MMP-1 at both, mRNA and protein lev-
els. Experiments using exogenous SMase ensured that the ASM/-
ﬁbroblasts used were principally able to upregulate MMP-1. Trans-
fection of ASM/-ﬁbroblasts with an expression plasmid of ASM
restored MMP-1 expression upon stimulation with IL-1b, compara-
ble with control ﬁbroblasts. Our data reveal that MMP-1 is onlyupregulated by IL-1b when ASM is present. Thus, activation of
ASM and generation of ceramide is not only induced by IL-1b but
is necessary for upregulation of MMP-1.
The present data also reveal that phosphorylation of ERK is
inadequate in ASM/-ﬁbroblasts after engagement with IL-1b. In
contrast, p38MAPK was rapidly phosphorylated in ASM-deﬁcient
cells and IL-8 was also clearly upregulated. Both effects were com-
parable with control ﬁbroblasts, demonstrating that activation of
the p38MAPK pathway was not dependent on ASM in our cell
model, thereby also excluding insensitivity of ASM-deﬁcient cells
to IL-1b.
Furthermore, we analyzed whether inhibition of ASM by imip-
ramine [30–32] is capable of reducing MMP-1 expression elicited
by IL-1b. Imipramine completely abolished the induction of
MMP-1 by IL-1b, indicating that inhibition of ASM is sufﬁcient to
regulate MMP-1 expression in human ﬁbroblasts. Inhibition of
NSM by L-carnitine did not reduce MMP-1 expression. Thus, ASM
is accountable for MMP-1 production in our cell model, whereas
NSM seems to be irrelevant.
Several cytokines and stimulatory processes activate ASM, fol-
lowed by rapid hydrolysis of plasma membrane sphingomyelin
to the second messenger ceramide [21–25]. Many of these stim-
uli are known to exert their signaling effects by activation of
MAPK pathways, which in turn increase MMP-1 expression
[33–37]. Previous studies already demonstrated the linkage of
sphingomyelin-derived lipids, exogenous short chain ceramides
or exogenous neutral SMase with activation of MAPK [38,39]
but the relationship of these kinases with endogenous SMases
and endogenous long chain ceramides still require deﬁnition.
Previous data by Reunanen et al. [14] and Bu et al. [15] sug-
gested that MMP-1 production by exogenous ceramide and
dhS1P is abrogated by inhibition of ERK whereas inhibition of
JNK or p38MAPK is not effective [15]. Consistent with these data,
ASM-deﬁcient ﬁbroblasts fail to generate ceramide and initiate
ERK phosphorylation, explaining the inability of ASM/ ﬁbro-
blasts to upregulate MMP-1 expression. The fact, that ASM-deﬁ-
cient ﬁbroblasts fail to phosphorylate ERK upon stimulation with
IL-1b indicate a blockade of signal initiation at a very early step
of signal transduction. Grassme et al. suggested that activity of
ASM mediates the release of ceramide in membrane microdo-
mains, with ceramide triggering the fusion of small membrane
rafts to larger signaling platforms which are required for the ini-
tiation of signaling [40]. Signaling processes dependent on such a
process of clustering are therefore blocked when ASM is deﬁcient
or the oligomerization of membrane microdomains is disturbed.
This mechanism would explain the suppression of MMP-1
expression by methyl-b-cyclodextrin in our experiments and also
the results by Bu et al. who used pertussis toxin to abrogate the
possibly G-protein-coupled effect of dhS1P-induced ERK1/2 phos-
phorylation [15]. Therefore, we propose the following model: cel-
lular stimulation by IL-1b leads to activation of ASM with
localized accumulation of ceramide and consecutive aggregation
of signaling molecules. This process is required to initiate the sig-
naling pathway of ERK1/2 activation and consecutive MMP-1
production, whereas other signaling pathways, as the activation
of p38MAPK with consecutive production of IL-8 do not depend
upon this mechanism. As a consequence, we provide evidence
for a new aspect of cellular generation of ceramide by ASM,
which is responsible for the regulation of ECM degradation by
MMP-1.
In summary, ASM is required to increase MMP-1 expression in
an ERK-dependent pathway. Inhibition of ASM may therefore offer
a therapeutic approach in diseases with increased MMP-1 expres-
sion, like tumor invasion and metastasis, pulmonary emphysema,
rheumatoid arthritis or intestinal and dermal ulcerations.
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